---
title: "JZYY: The net profit attributable to the parent company in the third quarter was 161 million yuan, an increase of 4.70% year-on-year"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/262584368.md"
description: "On October 24th, JZYY announced that in the third quarter of 2025, it achieved operating revenue of 792 million yuan, a year-on-year decrease of 7.59%; the net profit attributable to shareholders of the listed company was 161 million yuan, a year-on-year increase of 4.70%; basic earnings per share were 0.26 yuan"
datetime: "2025-10-24T09:26:50.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/262584368.md)
  - [en](https://longbridge.com/en/news/262584368.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/262584368.md)
---

# JZYY: The net profit attributable to the parent company in the third quarter was 161 million yuan, an increase of 4.70% year-on-year

On October 24th, JZYY announced that it achieved an operating income of 792 million yuan in the third quarter of 2025, a year-on-year decrease of 7.59%; the net profit attributable to shareholders of the listed company was 161 million yuan, a year-on-year increase of 4.70%; the basic earnings per share were 0.26 yuan

### Related Stocks

- [600750.CN](https://longbridge.com/en/quote/600750.CN.md)

## Related News & Research

- [China's Bio-Thera Gets US Nod for Golimumab Biosimilar](https://longbridge.com/en/news/286880573.md)
- [Desert Mountain Energy says ADEQ waiver clears McCauley Field well stimulation plan](https://longbridge.com/en/news/287080992.md)
- [Ameriwest moves historical Bornite drill core to Reno for re-logging, re-assays](https://longbridge.com/en/news/287060347.md)
- [<![CDATA[Pharmaceutical Executive Daily: TrumpRx Expands to Offer Over 600 Generic Drugs]]>](https://longbridge.com/en/news/286948461.md)
- [TrumpRx.gov Expands With More Than 600 Generic Medications](https://longbridge.com/en/news/286905168.md)